SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.
Public ClinicalTrials.gov record NCT02036645. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomised, Double-Blind, Placebo Controlled, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEDI1814 in Subjects With Mild to Moderate Alzheimer's Disease.
Study identification
- NCT ID
- NCT02036645
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 77 participants
Conditions and interventions
Conditions
Interventions
- MEDI1814 for IV injection Biological
- MEDI1814 for Subcutaneous Injection Biological
- IV Placebo Biological
- Placebo for Subcutaneous Injection Biological
Biological
Eligibility (public fields only)
- Age range
- 55 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 3, 2014
- Primary completion
- Sep 14, 2016
- Completion
- Sep 14, 2016
- Last update posted
- Jun 2, 2019
2014 – 2016
United States locations
- U.S. sites
- 10
- U.S. states
- 5
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Glendale | California | 91206 | — |
| Research Site | Long Beach | California | 90806 | — |
| Research Site | Panorama City | California | 91402 | — |
| Research Site | Hallandale | Florida | 33009 | — |
| Research Site | Hialeah | Florida | 33012 | — |
| Research Site | Miami | Florida | 33165 | — |
| Research Site | Orlando | Florida | 32806 | — |
| Research Site | Baltimore | Maryland | 21225 | — |
| Research Site | Oklahoma City | Oklahoma | 73112 | — |
| Research Site | Salt Lake City | Utah | 84106 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02036645, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 2, 2019 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02036645 live on ClinicalTrials.gov.